It feels like medical advancements bring new procedures and new treatments every day. That's mostly true. Unfortunately, improvements don't always come quite as quickly in every field of medical science. In fact, some technologies have remained virtually the same for literally decades.

One of those fields still mired in some decidedly old technology is the practice of joint replacement surgeries. Currently, there are over 1 million procedures each year in the U.S. to surgically replace a hip or put in a new knee. That number is expected to grow to 3.5 million by 2030. And most of those surgeries are handled in much the same manner as when the procedure first started gaining traction in the 1970s.

Consequently, all those years of hip and knee replacements have boosted the success rate of those surgeries, with about 90 percent now deemed successful. But are 90 percent of patients truly satisfied? While a new knee may technically work and be judged a success, many patients report varying levels of chronic pain connected to their procedure.

About 36 percent of total knee arthroplasty (TKA) patients say they experienced enough pain and complications afterward that they wouldn't have undergone the surgery with the benefit of hindsight 10 years later. In another survey, 1 in 5 patients reported they weren't happy with the results of their replacement.

According to experts, many of those complaints can be linked right back to the TKA process itself. Most surgeries are done using saws and jigs that prep the bone for generic implants that don't always fit like a glove. Surgeons of all experience levels usually eyeball proper placement and alignment, making a quick judgment call about whether that placement is correct. If they guess wrong, the patient could be dealing with years, even decades of everything from discomfort and soreness all the way up to significant chronic pain.

Invest in robotics as the future of joint replacement surgeries

 With so many displeased with the results of the half-century old method, Monogram Orthopedics is gaining some serious attention for its new joint replacement process. As the first company ready to market an active milling navigated robot arm with 3D-printed patient-optimized implants, Monogram is now seeking investors via SeedInvest to get more doctors and hospitals onboard with this advancement in joint replacement.

The Monogram process brings 2021 technology to the old 20th century joint replacement procedure. Rather than basing this delicate operation on generic implants and estimates, Monogram's approach starts with a CT scan to customize the procedure to the individual patient. Their 3D-printed implants are smaller, more stable, and conserve more natural bone for a custom-fitted new knee that's designed to fit each patient. Crafted to the specific case, a Monogram implant generates up to 270 percent less micromotion than a generic implant, offering greater stability and less chance for pain from the new joint.

The process is also handled by one of Monogram's robotic surgical arms, a navigated robot designed by a team of top surgeons and robotics experts. With an increased range of motion and ultra-precise calibrations, the implant can settle against the existing bone perfectly. That allows the bone to properly grow into the porous structure of the new knee and effectively bring the two together like tree roots into soil, all in a less invasive procedure.

Meanwhile, studies conducted with UCLA and the University of Nebraska Medical Center found the Monogram process was about 7 times more stable than current knee replacement techniques.

Join Monogram and next-gen joint replacement

Already backed by more than $20 million in investment, Monogram is now opening up their rollout to bring on further Series B investment. They're targeting science-savvy investors who see the growth potential of more accurate, more efficient, better-performing knee replacement surgeries. And with the $20 billion a year joint replacement market continuing to rocket up, Monogram is also poised to take this procedure from knees to other joint replacement surgeries like hips, ankles, shoulders, and spines.

 Right now, investors who back Monogram to the tune of $5,000 or more will also receive a 5 percent bonus on their investment, while anyone backing by at least $10,000 will earn a 10 percent increase to their stake. 

This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view Monogram Orthopedics offering circular as well as the risks associated with this offering.

Futurism fans: To create this content, a non-editorial team worked with an affiliate partner. We may collect a small commission on items purchased through this page. This post does not necessarily reflect the views or the endorsement of the editorial staff.

Share This Article